To study BC cell‐intrinsic PD‐L1 signals, we used CRISPR/Cas9 to knock PD‐L1 out in the well‐established mouse and human BC cell lines, MB49 and RT4, respectively. The gene discussed is CD274; the disease is breast cancer.